Literature DB >> 30569272

Metabolic health in normal-weight and obese individuals.

Matthias B Schulze1,2,3.   

Abstract

Cardiovascular complications are commonly associated with obesity. However, a subgroup of obese individuals may not be at an increased risk for cardiovascular complications; these individuals are said to have metabolically healthy obesity (MHO). In contrast, metabolically unhealthy individuals are at high risk of cardiovascular disease (CVD), irrespective of BMI; thus, this group can include individuals within the normal weight category (BMI 18.5-24.9 kg/m2). This review provides a summary of prospective studies on MHO and metabolically unhealthy normal-weight (MUHNW) phenotypes. Notably, there is ongoing dispute surrounding the concept of MHO, including the lack of a uniform definition and the potentially transient nature of metabolic health status. This review highlights the relevance of alternative measures of body fatness, specifically measures of fat distribution, for determining MHO and MUHNW. It also highlights alternative approaches of risk stratification, which account for the continuum of risk in relation to CVD, which is observable for most risk factors. Moreover, studies evaluating the transition from metabolically healthy to unhealthy phenotypes and potential determinants for such conversions are discussed. Finally, the review proposes several strategies for the use of epidemiological research to further inform the current debate on metabolic health and its determination across different stages of body fatness.

Entities:  

Keywords:  Cardiovascular diseases; Cohort studies; Metabolically benign; Obesity; Review

Mesh:

Year:  2018        PMID: 30569272     DOI: 10.1007/s00125-018-4787-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Seeking an Initial-Weight-Independent Metric in a Mediterranean Cohort of Gastric Bypass Patients: the %AWL Revisited.

Authors:  Marc Beisani; Fàtima Sabench Pereferrer; Ramón Vilallonga; Óscar González López; Alicia Molina López; Daniel Del Castillo Dejardin; Amador García Ruiz de Gordejuela; José Manuel Fort López-Barajas; Manel Armengol Carrasco
Journal:  Obes Surg       Date:  2021-01-04       Impact factor: 4.129

Review 2.  Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome.

Authors:  Sheetal Hardikar; Mary C Playdon; Prasoona Karra; Maci Winn; Svenja Pauleck; Alicja Bulsiewicz-Jacobsen; Lacie Peterson; Adriana Coletta; Jennifer Doherty; Cornelia M Ulrich; Scott A Summers; Marc Gunter
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

Review 3.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

4.  Lactobacillus plantarum Alleviates Obesity by Altering the Composition of the Gut Microbiota in High-Fat Diet-Fed Mice.

Authors:  Yong Ma; Yanquan Fei; Xuebing Han; Gang Liu; Jun Fang
Journal:  Front Nutr       Date:  2022-06-30

5.  Circulating prolactin level is increased in metabolically healthy obesity.

Authors:  Jia Liu; Lin Zhang; Jing Fu; Qiu Wang; Guang Wang
Journal:  Endocr Connect       Date:  2021-04-29       Impact factor: 3.335

6.  An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality.

Authors:  Anika Zembic; Nathalie Eckel; Norbert Stefan; Julia Baudry; Matthias B Schulze
Journal:  JAMA Netw Open       Date:  2021-05-03

7.  Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women.

Authors:  Flavia Giolo De Carvalho; Camila Fernanda Cunha Brandao; Vitor Rosetto Muñoz; Gabriela Batitucci; Maria Eduarda de Almeida Tavares; Giovana Rampazzo Teixeira; José Rodrigo Pauli; Leandro Pereira De Moura; Eduardo Rochete Ropelle; Dennys Esper Cintra; Adelino Sanchez Ramos da Silva; Márcia Varella Morandi Junqueira-Franco; Julio Sergio Marchini; Ellen Cristini De Freitas
Journal:  Amino Acids       Date:  2021-07-13       Impact factor: 3.520

8.  Short-Term Changes in Metabolically Healthy Overweight/Obesity Status Impact the Susceptibility to Type 2 Diabetes in Chinese Adults.

Authors:  Jie Min; Xiang Hu; Jiaoyue Zhang; Tianshu Zeng; Ying Wang; Shenghua Tian; Geng Liu; Xueyu Zhong; Kangli Qiu; Miaomiao Peng; Lulu Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

Review 9.  A Comprehensive Review of Almond Clinical Trials on Weight Measures, Metabolic Health Biomarkers and Outcomes, and the Gut Microbiota.

Authors:  Mark L Dreher
Journal:  Nutrients       Date:  2021-06-08       Impact factor: 5.717

10.  Biomarker-based visceral adiposity score and incident type 2 diabetes in the multiethnic cohort.

Authors:  Gertraud Maskarinec; Phyllis Ash Raquinio; Veronica W Setiawan; Thomas Ernst; Adrian A Franke; Steven D Buchthal; John A Shepherd; Lynne R Wilkens; Unhee Lim; Loïc Le Marchand
Journal:  Ann Epidemiol       Date:  2021-07-21       Impact factor: 6.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.